With the exception of support for the use of policosanol and garlic for hyperlipidaemia, the authors revealed an inconclusive evidence base. The complexity of this topic area, together with some methodological limitations of the review process, means that the extent to which the conclusions are reliable is unclear.
Results of the review
Ninety-two trials (approximately 129,000 participants) focusing on 15 dietary supplements were included in the review.
Overall, 5 trials achieved a quality of score of 5. The scores ranged from 2 to 5.
Cardiac outcomes.
All 3 trials of beta-carotene (n=85,091) reported no effect on cardiovascular outcomes; beta-carotene was associated with an increased risk of lung cancer in one of the included trials. Both trials of CoQ10 (n=217) found a statistically significant decrease in total cardiac events (p<0.02). One of 5 trials of vitamin E reported a significant decrease in major coronary events (n=1,035; p=0.005); the other four reported no effect on cardiovascular events. The highest quality scores (4) were in trials of vitamin E.
Hypertension.
Four of the 12 trials of calcium supplementation reported statistically significant reductions in either systolic or diastolic BP, or both (n=218; p<0.05); the other studies reported no change. Both trials of CoQ10 reported significant decreases in BP (n=142; p<0.05), as did both trials of garlic (n=107; p<0.05). Four of the 10 trials of magnesium supplementation reported some reductions in BP (n=144; p<0.05). The most frequent side-effect of magnesium was reported to be loose stools. Three trials of vitamin C supplementation (n=94) reported mixed results. One small trial (n=70) evaluating vitamin E reported reductions in systolic and diastolic BP (p<0.05). Small trials of blackcurrant seed and hawthorn reported no change in BP. The highest quality score (5) was in a trial of CoQ10.
Hyperlipidaemia.
Sample sizes in these studies ranged from 19 to 589. The highest quality scores (5) were found in trials of gugul and policosanol. Two trials of gugul (n=146) reported mixed results. Most of the 22 trials of policosanol reported a significant reduction in LDL (p<0.05). Ten trials reported increases in HDL (p<0.05); the other eight reported no effect. Three trials of magnesium-pyridoxal-phosphate-glutamate (n=255) reported mixed results. Seven of the 18 trials of garlic reported positive effects, mostly reductions in total cholesterol and LDL, with little effect on HDL (n=555; p<0.05). The only trial of artichoke extract (n=143), both trials of chromium (n=104) and the only trial of vitamin E (n=60) reported positive effects (p<0.05). Two trials of red clover (n=119) reported no effects. The reported sideeffects in all trials with positive effects on this condition were found to be mild, infrequent, or similar to placebo.
